Aug 15
|
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Aug 13
|
Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know
|
Aug 13
|
The 5 Most Interesting Analyst Questions From Guardant Health’s Q2 Earnings Call
|
Aug 13
|
GH Q2 Deep Dive: Strong Volume Growth and Product Expansion Amid Profitability Challenges
|
Aug 11
|
Multi Cancer Early Detection Market Forecast Report 2025-2033: A $4.3 Billion Market by 2033, as Market Set to Quadruple from $1 Billion Valuation in 2024
|
Aug 4
|
American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity
|
Aug 1
|
BioMarin Announces Appointment of Ian T. Clark to Board of Directors
|
Aug 1
|
Guardant Health Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|
Jul 31
|
Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference
|
Jul 31
|
Guardant Health Inc (GH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ...
|
Jul 30
|
Guardant Health (GH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
Jul 30
|
Guardant Health (NASDAQ:GH) Beats Expectations in Strong Q2, Guides for Strong Full-Year Sales
|
Jul 30
|
Guardant Health (GH) Reports Q2 Loss, Beats Revenue Estimates
|
Jul 30
|
Guardant Health: Q2 Earnings Snapshot
|
Jul 30
|
Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
|
Jul 30
|
Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
|
Jul 29
|
New RADIOHEAD Study Validates Use of Guardant Reveal Tissue-Free Monitoring for Earlier Detection of Immunotherapy Response in Advanced Cancer
|
Jul 29
|
Guardant Health (GH) Q2 Earnings: What To Expect
|
Jul 24
|
Cathie Wood's Bold AI and Genomics Playbooks Revealed
|
Jul 24
|
Cathie Wood Pours Millions into Nvidia and Biotech, Dumps Rocket Lab
|